199806-23-0 Usage
Uses
Used in Pharmaceutical Industry:
1H-Indole-2-carboxylic acid, 5-[[(1,1-dimethylethoxy)carbonyl]amino]-, phenylmethyl ester is used as a pharmaceutical intermediate for the synthesis of various drugs and medications. Its unique structure allows for the development of new compounds with potential therapeutic properties.
Used in Agrochemical Industry:
1H-Indole-2-carboxylic acid, 5-[[(1,1-dimethylethoxy)carbonyl]amino]-, phenylmethyl ester is used as an agrochemical intermediate for the development of pesticides and other agricultural chemicals. Its versatile structure enables the creation of new compounds with improved efficacy and selectivity.
Used in Organic Synthesis:
1H-Indole-2-carboxylic acid, 5-[[(1,1-dimethylethoxy)carbonyl]amino]-, phenylmethyl ester is used as a building block in organic synthesis for the creation of diverse chemical structures. Its functional groups allow for various chemical reactions, leading to the formation of new compounds with potential applications in various fields.
Used in Peptide Synthesis:
1H-Indole-2-carboxylic acid, 5-[[(1,1-dimethylethoxy)carbonyl]amino]-, phenylmethyl ester is used as a component in peptide synthesis, allowing for the formation of complex peptide structures with potential applications in research and drug development.
Check Digit Verification of cas no
The CAS Registry Mumber 199806-23-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,9,9,8,0 and 6 respectively; the second part has 2 digits, 2 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 199806-23:
(8*1)+(7*9)+(6*9)+(5*8)+(4*0)+(3*6)+(2*2)+(1*3)=190
190 % 10 = 0
So 199806-23-0 is a valid CAS Registry Number.
199806-23-0Relevant academic research and scientific papers
Synthesis and preliminary cytotoxicity study of glucuronide derivatives of CC-1065 analogues
Wang, Yuqiang,Yuan, Huiling,Wright, Susan C.,Wang, Hong,Larrick, James W.
, p. 1569 - 1575 (2007/10/03)
Glucuronide derivatives of CBI-bearing CC-1065 analogues have been synthesized, and their cytotoxicities tested against U937 leukemia cells. The new compounds show potent antitumor activity in vitro. Compounds 1 and 2, and their corresponding glucuronides
